Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls.

Annals of neurology - 1 Jan 1999

Moser A B, Kreiter N, Bezman L, Lu S, Raymond G V, Naidu S, Moser H W

Abstract excerpt

The assay of plasma very long chain fatty acids (VLCFAs), developed in our laboratory in 1981, has become the most widely used procedure for the diagnosis of X-linked adrenoleukodystrophy (X-ALD) and other peroxisomal disorders. We present here our 17 years' experience with this assay. Three VLCFA parameters, the level of hexacosanoic acid (C26:0), the ratio of C26:0 to tetracosanoic acid (C24:0), and of C26:0 to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Genotype

Share to Heterozygote

Share to Infant

Source

Identifiers

PMID: 9894883
DOI: 10.1002/1531-8249(199901)45:1<100::aid-art16>3.0.co;2-u

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls.PMID 9894883Read ↗

Plasma Very-Long-Chain Fatty Acids in X-Linked Adrenoleukodystrophy: Diagnostic Insights From a Clinical Laboratory Cohort.Semantic proximity Read ↗

X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies.Semantic proximity Read ↗

Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy.Semantic proximity Read ↗

Biochemical aspects of X-linked adrenoleukodystrophy.Semantic proximity Read ↗

X-linked Adrenoleukodystrophy, The Tunisian Experience.Semantic proximity Read ↗

Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described.Semantic proximity Read ↗

Adrenoleukodystrophy.Semantic proximity Read ↗

X-linked adrenoleukodystrophy with non-diagnostic plasma very long chain fatty acids.Semantic proximity Read ↗

Accumulation and impaired in vivo metabolism of di- and trihydroxycholestanoic acid in two patients.Semantic proximity Read ↗

Natural History of Clinical Phenotypes and Their Biochemical Correlates in Adult X-Linked Adrenoleukodystrophy.Semantic proximity Read ↗

Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctataSemantic proximity Read ↗

Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.